Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
306.4 INR | +5.06% | +17.10% | +22.73% |
04-18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
04-18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BIOCON LIMITED | Bio Therapeutic Drugs | +5.06% | +17.10% | +22.73% | +31.76% | -1.26% | 4.39B |
Technical Rankings Surperformance
- Stock Market
- Equities
- BIOCON Stock
- Charts Biocon Limited
- Comparison Chart